- Home
- HPE vs PODD Comparison
HPE vs PODD Comparison
Compare HPE & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPE
- PODD
- Stock Information
- Founded
- HPE 1939
- PODD 2000
- Country
- HPE United States
- PODD United States
- Employees
- HPE N/A
- PODD N/A
- Industry
- HPE Retail: Computer Software & Peripheral Equipment
- PODD Medical/Dental Instruments
- Sector
- HPE Technology
- PODD Health Care
- Exchange
- HPE Nasdaq
- PODD Nasdaq
- Market Cap
- HPE 23.8B
- PODD 21.5B
- IPO Year
- HPE N/A
- PODD 2007
- Fundamental
- Price
- HPE $17.97
- PODD $303.15
- Analyst Decision
- HPE Buy
- PODD Strong Buy
- Analyst Count
- HPE 12
- PODD 19
- Target Price
- HPE $21.75
- PODD $320.11
- AVG Volume (30 Days)
- HPE 16.9M
- PODD 782.7K
- Earning Date
- HPE 06-03-2025
- PODD 08-07-2025
- Dividend Yield
- HPE 2.90%
- PODD N/A
- EPS Growth
- HPE N/A
- PODD 67.46
- EPS
- HPE 1.04
- PODD 5.55
- Revenue
- HPE $31,649,000,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- HPE $8.79
- PODD $24.49
- Revenue Next Year
- HPE $5.43
- PODD $17.45
- P/E Ratio
- HPE $17.23
- PODD $54.39
- Revenue Growth
- HPE 11.79
- PODD 23.48
- 52 Week Low
- HPE $11.97
- PODD $173.00
- 52 Week High
- HPE $24.66
- PODD $329.33
- Technical
- Relative Strength Index (RSI)
- HPE 54.83
- PODD 47.89
- Support Level
- HPE $17.71
- PODD $299.47
- Resistance Level
- HPE $18.26
- PODD $310.18
- Average True Range (ATR)
- HPE 0.51
- PODD 6.79
- MACD
- HPE -0.07
- PODD -3.22
- Stochastic Oscillator
- HPE 43.22
- PODD 25.26
About HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company. Its portfolio enables hybrid clouds and hyperconverged infrastructure. It uses a primarily outsourced manufacturing model and employs 60,000 people worldwide.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.